Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Celularity Inc (NQ: CELU ) 3.160 +0.047 (+1.51%) Streaming Delayed Price Updated: 3:50 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Celularity Inc Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting June 03, 2024 Company presents results from in vivo studies of PT-CD16VS, a genetically modified allogeneic cell therapy derived from human placental circulating T (P-T) cells, in combination with various monoclonal... From Celularity Inc. Via GlobeNewswire Celularity Inc. to Host Investor and Analyst Research & Development Day April 22, 2024 Event Will Be Hosted On-site and Aired Virtually Highlighting Research, Clinical and Commercial Progress From Celularity Inc. Via GlobeNewswire Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products April 15, 2024 From Celularity Inc. Via GlobeNewswire Celularity and CH Trading Group Announce Product Distribution Agreement with Tamer Group to be the Exclusive Distributor for the Kingdom of Saudi Arabia January 11, 2023 From Celularity Inc. Via Business Wire Celularity and CH Trading Group Announce Territory Distribution Agreement for the Middle East January 11, 2023 From Celularity Inc. Via Business Wire CIRCLE H INTERNATIONAL (Ⓗ®™) SHARIA ADVISORY COUNCIL ISSUES UNPRECEDENTED FATWA FOR CONDITIONAL PERMITTED USE OF STEM CELLS, EXOSOMES, AND BIOMATERIALS IN RESEARCH, CLINICAL TRIALS AND TREATMENT December 20, 2022 New York, New York, United States - 12-20-2022 (PR Distribution™) - Via PR Distribution Topics Religion Exposures Religion Celularity Announces Halal Certification of its Advanced Cellular Therapeutics, Biomaterial Products and Business Model December 05, 2022 From Celularity Inc. Via Business Wire Celularity CEO Robert J. Hariri, M.D., Ph.D., Addresses FII Conference on “The Science and Technology for Extending Healthy Human Lifespan” November 30, 2022 From Celularity, Inc. Via Business Wire How Aging-Related Conditions Are Increasing The Treatment Burden For Older Patients August 13, 2021 Via FinancialNewsMedia Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.